Theravance Biopharma, Inc. - Ordinary Shares (TBPH): Price and Financial Metrics
GET POWR RATINGS... FREE!
TBPH POWR Grades
- Value is the dimension where TBPH ranks best; there it ranks ahead of 60.74% of US stocks.
- TBPH's strongest trending metric is Stability; it's been moving up over the last 200 days.
- TBPH's current lowest rank is in the Momentum metric (where it is better than 5.13% of US stocks).
TBPH Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for TBPH is -0.18 -- better than just 6.44% of US stocks.
- With a price/sales ratio of 18.27, Theravance Biopharma Inc has a higher such ratio than 89.73% of stocks in our set.
- TBPH's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 5.01% of US stocks.
- If you're looking for stocks that are quantitatively similar to Theravance Biopharma Inc, a group of peers worth examining would be EVGN, MYOV, NSTG, QTWO, and LLNW.
- Visit TBPH's SEC page to see the company's official filings. To visit the company's web site, go to www.theravance.com.
TBPH Price Target
For more insight on analysts targets of TBPH, see our TBPH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $30.63 | Average Broker Recommendation | 1.61 (Moderate Buy) |
TBPH Stock Price Chart Interactive Chart >
TBPH Price/Volume Stats
| Current price | $18.87 | 52-week high | $28.98 |
| Prev. close | $18.54 | 52-week low | $14.48 |
| Day low | $18.09 | Volume | 473,759 |
| Day high | $18.99 | Avg. volume | 333,855 |
| 50-day MA | $20.41 | Dividend yield | N/A |
| 200-day MA | $18.60 | Market Cap | 1.23B |
Theravance Biopharma, Inc. - Ordinary Shares (TBPH) Company Bio
Theravance Biopharma, Inc. engages in the research and development activities focusing on the diseases of the lung and gastrointestinal tract, and infectious diseases, as well as on the acute care setting markets. The company was founded in 2013 and is based in George Town, the Cayman Islands.
Latest TBPH News From Around the Web
Below are the latest news stories about Theravance Biopharma Inc that investors may wish to consider to help them evaluate TBPH as an investment opportunity.
Theravance (TBPH) Q1 Earnings Lag Estimates, Pipeline on TrackTheravance's (TBPH) loss narrows in the first quarter of 2021 while revenues decline year over year. |
Theravance Biopharma Inc (TBPH) Q1 2021 Earnings Call TranscriptTBPH earnings call for the period ending March 31, 2021. |
Increases to Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation Might Cool off for nowIn the past three years, shareholders of Theravance Biopharma, Inc. ( NASDAQ:TBPH ) have seen a loss on their... |
Theravance Bio (TBPH) Up 10.1% Since Last Earnings Report: Can It Continue?Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Are Theravance Biopharma, Inc. (NASDAQ:TBPH) Investors Paying Above The Intrinsic Value?Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Theravance Biopharma... |
TBPH Price Returns
| 1-mo | -8.18% |
| 3-mo | -5.41% |
| 6-mo | 6.85% |
| 1-year | -33.77% |
| 3-year | -25.36% |
| 5-year | 7.46% |
| YTD | 6.19% |
| 2020 | -31.36% |
| 2019 | 1.17% |
| 2018 | -8.25% |
| 2017 | -12.52% |
| 2016 | 94.51% |
Continue Researching TBPH
Here are a few links from around the web to help you further your research on Theravance Biopharma Inc's stock as an investment opportunity:Theravance Biopharma Inc (TBPH) Stock Price | Nasdaq
Theravance Biopharma Inc (TBPH) Stock Quote, History and News - Yahoo Finance
Theravance Biopharma Inc (TBPH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...